Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.
暂无分享，去创建一个
S. Litwin | G. Hudes | R. Greenberg | F. Nathan | L. Gomella | N. Haas | C. Khater | B. Giantonio | C. McAleer | M. Cornfield | E. Ross | S. Roethke | Naomi B. Haas | Faith E. Nathan | Christina Khater | Mark Cornfield | Richard N. Greenberg | Leonard G. Gomella | Samuel Litwin | Eric A. Ross